Detection of dengue virus nonstructural protein 1 (NS1) by using ELISA as a useful laboratory diagnostic method for dengue virus infection of international travelers

Journal of Travel Medicine

Volumn 20, Issue 3, 2013, Pages 185-193

  Moi, Meng Ling ^a   Omatsu, Tsutomu ^a   Tajima, Shigeru ^a   Lim, Chang Kweng ^a   Kotaki, Akira ^a   Ikeda, Makiko ^a   Harada, Fumiue ^a   Ito, Mikako ^a   Saijo, Masayuki ^a   Kurane, Ichiro ^a   Takasaki, Tomohiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; NONSTRUCTURAL PROTEIN 1;

AFRICA; ANTIGEN DETECTION; ARTICLE; ASIA; BLOOD SAMPLING; CENTRAL AMERICA; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; JAPAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PACIFIC ISLANDS; PRIMARY INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY INFECTION; SERODIAGNOSIS; SEROTYPE; SOUTH AMERICA; TRAVEL; VIRUS DETECTION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; COMPARATIVE EFFECTIVENESS RESEARCH; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN M; INTERNATIONALITY; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS; TRAVEL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84876280833     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12018     Document Type: Article

References (41)

1. World Health Organization. Dengue and dengue haemorrhagic fever. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/index.html, 2009. (Accessed 2012 Feb 20)
2. Knudsen AB, Slooff R,. Vector-borne disease problems in rapid urbanization: new approaches to vector control. Bull World Health Organ 1992; 70: 1-6.
3. Xu G, Dong H, Shi N, et al. An outbreak of dengue virus serotype 1 infection in Cixi, Ningbo, People's Republic of China, 2004, associated with a traveler from Thailand and high density of Aedes albopictus. Am J Trop Med Hyg 2007; 76: 1182-1188.
4. Takasaki T, Kotaki A, Lim CK, et al. Arbovirus infections: the challenges of controlling an ever-present enemy. J Disaster Res 2009; 4: 322-328.
5. Pandey BD, Rai SK, Morita K, Kurane I,. First case of dengue virus infection in Nepal. Nepal Med Coll J 2004; 6: 157-159.
6. Dorji T, Yoon IK, Holmes EC, et al. Diversity and origin of dengue virus serotypes 1, 2, and 3, Bhutan. Emerg Infect Dis 2009; 15: 1630-1632.
7. La Ruche G, Souarès Y, Armengaud A, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill 2010; 15: 19676.
8. National Institute of Infectious Diseases, Ministry of Health, Labour and Welfare. Dengue fever, dengue hemorrhagic fever and chikungunya fever importation in Japan, as of May 2011. Inf Agents Surveill Rep 2011; 32: 159-160.
9. Halstead SB,. Dengue. Lancet 2007; 370: 1644-1652.
10. Gubler DJ,. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11: 480-496.
11. Srikiatkhachorn A, Gibbons RV, Green S, et al. Dengue hemorrhagic fever: the sensitivity and specificity of the World Health Organization definition for identification of severe cases of dengue in Thailand, 1994-2005. Clin Infect Dis 2010; 50: 1135-1143.
12. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control, new edition. Geneva: World Health Organization, 2009.
13. Alcon S, Talarmin A, Debruyne M, et al. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002; 40: 376-381.
14. Bessoff K, Delorey M, Sun W, Hunsperger E,. Comparison of two commercially available dengue virus (DENV) NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for diagnosis of acute DENV infection. Clin Vaccine Immunol 2008; 15: 1513-1518.
15. Moi ML, Lim CK, Kotaki A, et al. Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection. J Infect Dis 2011; 203: 1405-1414.
16. Moi ML, Takasaki T, Kotaki A, et al. Importation of dengue virus type 3 to Japan from Tanzania and Cote d'Ivoire. Emerg Infect Dis 2010; 16: 1770-1772.
17. McBride WJ,. Evaluation of dengue NS1 test kits for the diagnosis of dengue fever. Diagn Microbiol Infect Dis 2009; 64: 31-36.
18. Wang SM, Sekaran SD,. Evaluation of a commercial SD dengue virus NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection. J Clin Microbiol 2010; 48: 2793-2797.
19. Lowry R. VassarStats: website for statistical computation, 1998-2011. Available at: http://vassarstats.net/ 1998. (Accessed 2012 Apr 9).
20. Blacksell SD, Mammen MP Jr, Thongpaseuth S, et al. Evaluation of the Panbio dengue virus nonstructural 1 antigen detection and immunoglobulin M antibody enzyme-linked immunosorbent assays for the diagnosis of acute dengue infections in Laos. Diagn Microbiol Infect Dis 2008; 60: 43-49.
21. Blacksell SD, Jarman RG, Gibbons RV, et al. Comparison of seven commercial antigen and antibody detection ELISAs for acute dengue infection. Clin Vaccine Immunol 2012; 19: 804-810.
22. Bisordi I, Rocco IM, Suzuki A, et al. Evaluation of dengue NS1 antigen detection for diagnosis in public health laboratories, São Paulo State, 2009. Rev Inst Med Trop São Paulo 2011; 53: 315-320.
23. Castro-Jorge LA, Machado PR, Fávero CA, et al. Clinical evaluation of the NS1 antigen-capture ELISA for early diagnosis of dengue virus infection in Brazil. J Med Virol 2010; 82: 1400-1405.
24. Chaterji S, Allen JC Jr, Chow A, et al. Evaluation of the NS1 rapid test and the WHO dengue classification schemes for use as bedside diagnosis of acute dengue fever in adults. Am J Trop Med Hyg 2011; 84: 224-228.
25. Kumarasamy V, Wahab AH, Chua SK, et al. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J Virol Methods 2007; 140: 75-79.
26. Lima Mda R, Nogueira RM, Schatzmayr HG, dos Santos FB,. Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil. PLoS Negl Trop Dis 2010; 4: e738.
27. Sugimoto M, Haseyama M, Ishida Y, et al. Evaluation of nonstructural 1 protein rapid test for dengue virus at the Narita Airport Quarantine Station, Japan. Jpn J Infect Dis 2011; 64: 169-170.
28. Zainah S, Wahab AH, Mariam M, et al. Performance of a commercial rapid dengue NS1 antigen immunochromatography test with reference to dengue NS1 antigen-capture ELISA. J Virol Methods 2009; 155: 157-160.
29. Blacksell SD, Jarman RG, Bailey MS, et al. Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy. Clin Vaccine Immunol 2011; 18: 2095-2101.
30. Xu H, Di B, Pan YX, et al. Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: implications for early diagnosis and serotyping of dengue virus infections. J Clin Microbiol 2006; 44: 2872-2878.
31. Tricou V, Minh NN, Farrar J, et al. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl Trop Dis 2011; 5: e1309.
32. Duong V, Ly S, Lorn Try P, et al. Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis 2011; 5: e1244.
33. Guzman MG, Jaenisch T, Gaczkowski R, et al. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 2010; 4: e811.
34. Fox A, Hoa LNM, Simmons CP, Wolbers M, et al. Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis 2011; 5: e967.
35. Osorio L, Ramirez M, Bonelo A, et al. Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection. Virol J 2010; 7: 361.
36. Vazquez S, Ruiz D, Barrero R, et al. Kinetics of dengue virus NS1 protein in dengue 4-confirmed adult patients. Diagn Microbiol Infect Dis 2010; 68: 46-49.
37. Duyen HT, Ngoc TV, Ha do T, et al. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J Infect Dis 2011; 203: 1292-1300.
38. Tricou V, Vu HT, Quynh NV, et al. Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect Dis 2010; 10: 142.
39. Fry SR, Meyer M, Semple MG, et al. The diagnostic sensitivity of dengue rapid test assays is significantly enhanced by using a combined antigen and antibody testing approach. PLoS Negl Trop Dis 2011; 5: e1199.
40. Shu PY, Yang CF, Kao JF, et al. Application of the dengue virus NS1 antigen rapid test for on-site detection of imported dengue cases at airports. Clin Vaccine Immunol 2009; 16: 589-591.
41. Huhtamo E, Hasu E, Uzcátegui NY, et al. Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology. J Clin Virol 2010; 47: 49-53.